- Global Pharma News & Resources

AEVIS VICTORIA SA: Operating revenues at 30 September 2021 up sharply to CHF 620.0 million (2020: CHF 509.9 million; 2019: CHF 513.9 million)

AEVIS VICTORIA SA / Key word(s): 9 Month figures

17-Nov-2021 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.

Ad hoc announcement pursuant to Art. 53 LR

Fribourg, 17 November 2021

AEVIS VICTORIA SA: Operating revenues at 30 September 2021 up sharply to CHF 620.0 million (2020: CHF 509.9 million; 2019: CHF 513.9 million)

The investment company AEVIS VICTORIA SA (AEVIS) achieved consolidated revenues of CHF 620.0 million at the end of September 2021, which represents a strong increase compared to 2020 and 2019. This result corresponds to a growth of 21.6%, including an organic growth of 16.2%, compared to the same period in 2020. This result demonstrates the gradual normalization of the situation in AEVIS' two main divisions, Healthcare and Hospitality.

Swiss Medical Network achieved revenues of CHF 522.2 million (2020: CHF 436.4 million), up 19.7%, and Victoria-Jungfrau, the hospitality division, achieved revenues of CHF 82.6 million (2020: CHF 60.5 million), up 36.6%. The Hôpital du Jura Bernois SA, which generates annual revenues of around CHF 120 million, has been consolidated since September 1st, 2021.

Third quarter revenues of AEVIS increased by 28.7% to CHF 210.3 million (2020: CHF 163.3 million). Swiss Medical Network could improve its revenues by 25.1% to CHF 177.5 million (2020: CHF 141.9 million), driven by the acquisition of majority stakes in Hôpital du Jura bernois SA, Rosenklinik AG and Klinik Pyramide am See AG. The hospitality division saw its third quarter revenues increase by 77.3% to CHF 29.7 million.

The Victoria-Jungfrau hospitality division is continuing its recovery with contrasting results depending on the establishments. To date, bookings for the winter season are up, with the majority of mountain hotels opening their winter season on December 17th, 2021.

In the first nine months of 2021, the organic growth of Swiss Medical Network was encouraging, while the Hospitality division continues to face Covid-related restrictions and requirements. AEVIS continues to refrain from publishing revenue or margin targets at the Group level for fiscal year 2021.

Based on the substantial profit at the holding level of more than CHF 200 million already achieved at half-year, the Board of Directors of AEVIS intends to propose the distribution of a dividend at the next General Shareholders Meeting in 2022. The Board will decide on the amount of the distribution after the end of the 2021 financial year and the assessment of the holding profitability level.

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey,, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren,, +41 (0) 79 635 04 10

AEVIS VICTORIA SA - Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network SA (90%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, Victoria-Jungfrau AG, a luxury hotel group managing nine luxury hotels in Switzerland, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, a hospitality real estate division, Medgate (40%), the leading telemedicine provider in Switzerland, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW).

End of ad hoc announcement

Editor Details

Last Updated: 17-Nov-2021